secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001731122-24-000372
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro receives termination notice for License Agreement covering HIV candidate RENB-HV-01
--------------------------------------------------------------------------------

- Weird Science LLC terminated the License Agreement for RENB-HV-01 on March 1, 2024.
- Renovaro had previously deprioritized RENB-HV-01 as costly and long-term, focusing on faster pipelines.
- Lead candidate is now RENB-DC-11, a potential cancer vaccine for solid tumors; HIV programs continue under other licenses.
- Company is evaluating all options regarding the termination and does not acknowledge the termination as effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000372/0001731122-24-000372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000372/e5476_8k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-000372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer